The Idylla™ ThyroidPrint® test, developed by GeneproDX, evaluates the gene expression profile of a fine needle aspiration (FNA) sample, enabling laboratory assessment of the risk classification for indeterminate thyroid nodules (Bethesda III-IV). This test helps avoid unnecessary thyroid surgeries and reduces healthcare costs.
Benefits of the Idylla ThyroidPrint test:
● The test is performed using an FNA sample.
● Can be conducted locally in your own laboratory.
● Thanks to a fully automated protocol, the turnaround time for the test is approximately 3 hours.
● The test measures the expression of 10 genes.
● The test helps identify nodules with a low cancer risk, with an NPV value of 95%.